1. Home
  2. CNX vs IOVA Comparison

CNX vs IOVA Comparison

Compare CNX & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNX Resources Corporation

CNX

CNX Resources Corporation

HOLD

Current Price

$38.51

Market Cap

5.8B

Sector

Energy

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.44

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNX
IOVA
Founded
1860
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
1.4B
IPO Year
1998
2008

Fundamental Metrics

Financial Performance
Metric
CNX
IOVA
Price
$38.51
$3.44
Analyst Decision
Sell
Buy
Analyst Count
7
10
Target Price
$35.71
$9.11
AVG Volume (30 Days)
1.9M
14.3M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
763.33
14.84
EPS
3.98
N/A
Revenue
$2,239,134,000.00
N/A
Revenue This Year
N/A
$51.55
Revenue Next Year
$11.01
$37.55
P/E Ratio
$9.71
N/A
Revenue Growth
76.76
N/A
52 Week Low
$27.68
$1.64
52 Week High
$43.62
$5.63

Technical Indicators

Market Signals
Indicator
CNX
IOVA
Relative Strength Index (RSI) 40.43 44.16
Support Level $36.33 $2.02
Resistance Level $42.50 $4.34
Average True Range (ATR) 1.63 0.25
MACD -0.36 -0.11
Stochastic Oscillator 18.29 19.21

Price Performance

Historical Comparison
CNX
IOVA

About CNX CNX Resources Corporation

CNX Resources Corp is an independent natural gas development, production, midstream and technology company centered in the Appalachian Basin. It is focused on unconventional shale formations, prominently the Marcellus Shale and Utica Shale, in Pennsylvania, Ohio and West Virginia. Additionally, the company operates and develops Coalbed Methane (CBM) properties in Virginia. the company has two reportable segments: Shale and Coalbed Methane. The majority of the company's revenue is derived from the Shale segment.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: